C-terminal binding protein: A molecular link between metabolic imbalance and epigenetic regulation in breast cancer

International Journal of Cell Biology

Volumn , Issue , 2013, Pages

  Byun, Jung S ^a   Gardner, Kevin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARPN ALPHA PROTEIN; BINDING PROTEIN; BRCA1 PROTEIN; C TERMINAL BINDING PROTEIN; CARBOHYDRATE; CDYL PROTEIN; COREST PROTEIN; CTIP PROTEIN; EHMT1 PROTEIN; EVI 1 PROTEIN; G9A PROTEIN; GIANT PROTEIN; HAIRY PROTEIN; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 7; KNIRPS PROTEIN; KRUPPEL PROTEIN; LSD1 PROTEIN; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TRANSCRIPTION FACTOR ELK 4; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; WIZ PROTEIN; ZFH 1 PROTEIN; ZNF741 PROTEIN;

BREAST CANCER; CANCER CELL; CANCER RISK; CARBOHYDRATE METABOLISM; CARCINOGENESIS; CELL FATE; CELL FUNCTION; CONCENTRATION (PARAMETERS); CYTOPLASM; DIABETES MELLITUS; DISEASE ASSOCIATION; ENERGY EXPENDITURE; EPIGENETICS; FEMALE; GENE CONTROL; HUMAN; METABOLIC REGULATION; MOLECULAR MECHANICS; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EID: 84878658181     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2013/647975     Document Type: Review

References (196)

1. Hajdu S. I., A note from history: landmarks in history of cancer, part 1. Cancer 2011 117 5 1097 1102 2-s2.0-79952010844 10.1002/cncr.25553
2. Virchow R., An address on the value of pathological experiments. British Medical Journal 1881 2 1075 198 203
3. Jackson S. P., Bartek J., The DNA-damage response in human biology and disease. Nature 2009 461 7267 1071 1078 2-s2.0-70350504453 10.1038/nature08467
4. Ciccia A., Elledge S. J., The DNA damage response: making it safe to play with knives. Molecular Cell 2010 40 2 179 204 2-s2.0-78649336706 10.1016/j.molcel.2010.09.019
5. Schneider B. P., Winer E. P., Foulkes W. D., Garber J., Perou C. M., Richardson A., Sledge G. W., Carey L. A., Triple-negative breast cancer: risk factors to potential targets. Clinical Cancer Research 2008 14 24 8010 8018 2-s2.0-58149359842 10.1158/1078-0432.CCR-08-1208
6. Peppercorn J., Perou C. M., Carey L. A., Molecular subtypes in breast cancer evaluation and management: divide and conquer. Cancer Investigation 2008 26 1 1 10 2-s2.0-37849041082 10.1080/07357900701784238
7. Rowe B. P., Glazer P. M., Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms. Breast Cancer Research 2010 12 2, article 203 2-s2.0-77956631770 10.1186/bcr2566
8. Perou C. M., Molecular stratification of triple-negative breast cancers. The Oncologist 2011 16 supplement 1 61 70 2-s2.0-79959520764
9. Perou C. M., Molecular stratification of triple-negative breast cancers. The Oncologist 2010 15 supplement 5 39 48 2-s2.0-79952654970
10. Perou C. M., Sørile T., Eisen M. B., Van De Rijn M., Jeffrey S. S., Ress C. A., Pollack J. R., Ross D. T., Johnsen H., Akslen L. A., Fluge Ø., Pergammenschlkov A., Williams C., Zhu S. X., Lønning P. E., Børresen-Dale A. L., Brown P. O., Botstein D., Molecular portraits of human breast tumours. Nature 2000 406 6797 747 752 2-s2.0-0034680102 10.1038/35021093
11. Prat A., Perou C. M., Mammary development meets cancer genomics. Nature Medicine 2009 15 8 842 844 2-s2.0-68349150810 10.1038/nm0809-842
12. Anders C. K., Deal A. M., Miller C. R., Khorram C., Meng H., Burrows E., Livasy C., Fritchie K., Ewend M. G., Perou C. M., Carey L. A., The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer 2011 117 8 1602 1611 2-s2.0-79953783229 10.1002/cncr.25746
13. Hall J. M., Lee M. K., Newman B., Morrow J. E., Anderson L. A., Huey B., King M. C., Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990 250 4988 1684 1689 2-s2.0-0025613812 (Pubitemid 120031871)
14. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennet L. M., Ding W., Bell R., Rosenthal J., Hussey C., Tran T., McClure M., Frye C., Hattier T., Phelps R., Haugen-Strano A., A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994 266 5182 66 71 2-s2.0-0028113345 (Pubitemid 24345325)
15. Wooster R., Bignell G., Lancaster J., Identification of the breast cancer susceptibility gene BRCA2. Nature 1995 378 789 792 (Pubitemid 26004412)
16. Ford D., Easton D. F., Stratton M., Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. The American Journal of Human Genetics 1998 62 3 676 689 (Pubitemid 28164626)
17. Palacios J., Honrado E., Osorio A., Diez O., Rivas C., Benítez J., Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. Journal of the National Cancer Institute 2004 96 9 712 714 2-s2.0-2442614103
18. Honrado E., Osorio A., Palacios J., Benitez J., Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 2006 25 43 5837 5845 2-s2.0-33749025026 10.1038/sj.onc.1209875 (Pubitemid 44453439)
19. Turner N. C., Reis-Filho J. S., Russell A. M., Springall R. J., Ryder K., Steele D., Savage K., Gillett C. E., Schmitt F. C., Ashworth A., Tutt A. N., BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 2007 26 14 2126 2132 2-s2.0-33847022042 10.1038/sj.onc.1210014 (Pubitemid 46514749)
20. Calle E. E., Rodriguez C., Walker-Thurmond K., Thun M. J., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults. The New England Journal of Medicine 2003 348 17 1625 1638 2-s2.0-0037464510 10.1056/NEJMoa021423 (Pubitemid 36459468)
21. Calle E. E., Thun M. J., Obesity and cancer. Oncogene 2004 23 38 6365 6378 2-s2.0-4444237280 10.1038/sj.onc.1207751 (Pubitemid 39265505)
22. Calle E. E., Kaaks R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews Cancer 2004 4 8 579 591 2-s2.0-3543072186 (Pubitemid 39025053)
23. Kotsopoulos J., Olopado O. I., Ghadirian P., Lubinski J., Lynch H. T., Isaacs C., Weber B., Kim-Sing C., Ainsworth P., Foulkes W. D., Eisen A., Sun P., Narod S. A., Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research 2005 7 5 R833 R843 2-s2.0-33644876518
24. Wellen K. E., Hotamisligil G. S., Inflammation, stress, and diabetes. The Journal of Clinical Investigation 2005 115 5 1111 1119 2-s2.0-18244370762 10.1172/JCI200525102 (Pubitemid 40629025)
25. Wellen K. E., Hotamisligil G. S., Obesity-induced inflammatory changes in adipose tissue. The Journal of Clinical Investigation 2003 112 12 1785 1788 2-s2.0-0347985272 10.1172/JCI200320514 (Pubitemid 38063699)
26. Wellen K. E., Thompson C. B., Cellular metabolic stress: considering how cells respond to nutrient excess. Molecular Cell 2010 40 2 323 332 2-s2.0-78649391422 10.1016/j.molcel.2010.10.004
27. Turrens J. F., Mitochondrial formation of reactive oxygen species. Journal of Physiology 2003 552 2 335 344 2-s2.0-0142150051 10.1113/jphysiol. 2003.049478 (Pubitemid 37321833)
28. Murphy M. P., How mitochondria produce reactive oxygen species. Biochemical Journal 2009 417 1 1 13 2-s2.0-58249093939 10.1042/BJ20081386
29. Postigo A. A., Dean D. C., Differential expression and function of members of the zfh-1 family of zinc finger/homeodomain repressors. Proceedings of the National Academy of Sciences of the United States of America 2000 97 12 6391 6396 2-s2.0-0034612270 10.1073/pnas.97.12.6391 (Pubitemid 30412724)
30. Poortinga G., Watanabe M., Parkhurst S. M. M., Drosophila CtBP: a Hairy-interacting protein required for embryonic segmentation and Hairy-mediated transcriptional repression. EMBO Journal 1998 17 7 2067 2078 2-s2.0-0032055490 10.1093/emboj/17.7.2067 (Pubitemid 28154535)
31. Nibu Y., Zhang H., Levine M., Interaction of short-range repressors with Drosophila CtBP in the embryo. Science 1998 280 5360 101 104 2-s2.0-0032478737 10.1126/science.280.5360.101 (Pubitemid 28169090)
32. Nibu Y., Levine M. S., CtBP-dependent activities of the short-range giant repressor in the Drosophila embryo. Proceedings of the National Academy of Sciences of the United States of America 2001 98 11 6204 6208 2-s2.0-0035933105 10.1073/pnas.111158298 (Pubitemid 32488217)
33. Postigo A. A., Dean D. C., ZEB represses transcription through interaction with the corepressor CtBP. Proceedings of the National Academy of Sciences of the United States of America 1999 96 12 6683 6688 2-s2.0-0033536047 10.1073/pnas.96.12.6683 (Pubitemid 29274943)
34. Schaeper U., Subramanian T., Lim L., Boyd J. M., Chinnadurai G., Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif. The Journal of Biological Chemistry 1998 273 15 8549 8552 2-s2.0-0032502782 10.1074/jbc.273.15.8549 (Pubitemid 28176126)
35. Yu X., Wu L. C., Bowcock A. M., Aronheim A., Baer R., The C-terminal (BRCT) domains of BRCA1 interact in vive with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. The Journal of Biological Chemistry 1998 273 39 25388 25392 2-s2.0-0032566753 10.1074/jbc.273.39.25388 (Pubitemid 28443306)
36. Criqui-Filipe P., Ducret C., Maira S. M., Wasylyk B., Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. EMBO Journal 1999 18 12 3392 3403 2-s2.0-0033564261 10.1093/emboj/18.12.3392 (Pubitemid 29276585)
37. van Vliet J., Turner J., Crossley M., Human Kruppel-like factor 8: a CACCC-box binding protein that associates with CtBP and represses transcription. Nucleic Acids Research 2000 28 9 1955 1962 2-s2.0-0034178250 (Pubitemid 30229662)
38. Grooteclaes M., Deveraux Q., Hildebrand J., Zhang Q., Goodman R. H., Frisch S. M., C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proceedings of the National Academy of Sciences of the United States of America 2003 100 8 4568 4573 2-s2.0-0345352743 10.1073/pnas.0830998100 (Pubitemid 36457771)
39. Izutsu K., Kurokawa M., Imai Y., Maki K., Mitani K., Hirai H., The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling. Blood 2001 97 9 2815 2822 2-s2.0-0035353203 10.1182/blood.V97.9.2815
40. Zhang C. L., McKinsey T. A., Lu J. R., Olson E. N., Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. The Journal of Biological Chemistry 2001 276 1 35 39 2-s2.0-0035808460 10.1074/jbc.M007364200 (Pubitemid 32050285)
41. Subramanian T., Chinnadurai G., Association of class I histone deacetylases with transcriptional corepressor CtBP. FEBS Letters 2003 540 1-3 255 258 2-s2.0-0037430968 10.1016/S0014-5793(03)00275-8 (Pubitemid 36398067)
42. Shi Y., Sawada J. I., Sui G., Affar E. B., Whetstine J. R., Lan F., Ogawa H., Luke M. P. S., Nakatani Y., Shi Y., Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 2003 422 6933 735 738 2-s2.0-0242669199 10.1038/nature01550 (Pubitemid 36514114)
43. McDonald O. G., Wu H., Timp W., Doi A., Feinberg A. P., Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nature Structural & Molecular Biology 2011 18 8 867 874 2-s2.0-79961023271 10.1038/nsmb.2084
44. Ueda J., Tachibana M., Ikura T., Shinkai Y., Zinc finger protein Wiz links G9a/GLP histone methyltransferases to the co-repressor molecule CtBP. The Journal of Biological Chemistry 2006 281 29 20120 20128 2-s2.0-33745999467 10.1074/jbc.M603087200 (Pubitemid 44065786)
45. Kim J. H., Cho E. J., Kim S. T., Youn H. D., CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain. Nature Structural & Molecular Biology 2005 12 5 423 428 2-s2.0-20444468137 10.1038/nsmb924 (Pubitemid 43085902)
46. Zhang Y., Yang X., Gui B., Corepressor protein CDYL functions as a molecular bridge between polycomb repressor complex 2 and repressive chromatin mark trimethylated histone lysine 27. The Journal of Biological Chemistry 2011 286 49 42414 42425
47. Pagan J. K., Arnold J., Hanchard K. J., Kumar R., Bruno T., Jones M. J. K., Richard D. J., Forrest A., Spurdle A., Verdin E., Crossley M., Fanciulli M., Chenevix-Trench G., Young D. B., Khanna K. K., A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP. The Journal of Biological Chemistry 2007 282 20 15248 15257 2-s2.0-34447538496 10.1074/jbc.M700246200 (Pubitemid 47093329)
48. Vo N., Fjeld C., Goodman R. H., Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP. Molecular and Cellular Biology 2001 21 18 6181 6188 2-s2.0-0035724042 10.1128/MCB.21.18.6181-6188.2001 (Pubitemid 34263518)
49. Jack B. H. A., Crossley M., GATA proteins work together with Friend of GATA (FOG) and C-terminal Binding Protein (CTBP) co-regulators to control adipogenesis. The Journal of Biological Chemistry 2010 285 42 32405 32414 2-s2.0-77957786157 10.1074/jbc.M110.141317
50. Kajimura S., Seale P., Tomaru T., Erdjument-Bromage H., Cooper M. P., Ruas J. L., Chin S., Tempst P., Lazar M. A., Spiegelman B. M., Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes and Development 2008 22 10 1397 1409 2-s2.0-44149113548 10.1101/gad.1666108 (Pubitemid 351717529)
51. Mirnezami A. H., Campbell S. J., Darley M., Primrose J. N., Johnson P. W. M., Blaydes J. P., Hdm2 recruits a hypoxia-sensitive corepressor to negatively regulate p53-dependent transcription. Current Biology 2003 13 14 1234 1239 2-s2.0-0038714732 10.1016/S0960-9822(03)00454-8 (Pubitemid 36872947)
52. Deltour S., Pinte S., Guerardel C., Wasylyk B., Leprince D., The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Molecular and Cellular Biology 2002 22 13 4890 4901 2-s2.0-0036274143 10.1128/MCB.22.13.4890-4901.2002 (Pubitemid 34620422)
53. Zhang Q., Wang S. Y., Fleuriel C., Leprince D., Rocheleau J. V., Piston D. W., Goodman R. H., Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proceedings of the National Academy of Sciences of the United States of America 2007 104 3 829 833 2-s2.0-33846505019 10.1073/pnas.0610590104 (Pubitemid 46154696)
54. Mendez L. M., Polo J. M., Yu J. J., Krupski M., Ding B. B., Melnick A., Ye B. H., CtBP is an essential corepressor for BCL6 autoregulation. Molecular and Cellular Biology 2008 28 7 2175 2186 2-s2.0-41149139718 10.1128/MCB.01400-07 (Pubitemid 351429965)
55. Stankovic-Valentin N., Verger A., Deltour-Balerdi S., Quinlan K. G. R., Crossley M., Leprince D., A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP. FEBS Journal 2006 273 13 2879 2890 2-s2.0-33745222095 10.1111/j.1742-4658.2006.05301.x
56. Keutgens A., Shostak K., Close P., Zhang X., Hennuy B., Aussems M., Chapelle J. P., Viatour P., Gothot A., Fillet M., Chariot A., The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1. Molecular and Cellular Biology 2010 30 16 4006 4021 2-s2.0-77955650050 10.1128/MCB.01600-09
57. Verger A., Quinlan K. G. R., Crofts L. A., Spanò S., Corda D., Kable E. P. W., Braet F., Crossley M., Mechanisms directing the nuclear localization of the CtBP family proteins. Molecular and Cellular Biology 2006 26 13 4882 4894 2-s2.0-33745186109 10.1128/MCB.02402-05 (Pubitemid 43955806)
58. Koipally J., Georgopoulos K., Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity. The Journal of Biological Chemistry 2000 275 26 19594 19602 2-s2.0-0034733563 10.1074/jbc.M000254200 (Pubitemid 30441553)
59. Alpatov R., Munguba G. C., Caton P., Jeong H. J., Shi Y., Shi Y., Hunt M. E., Sugrue S. P., Nuclear speckle-associated protein Pnn/DRS binds to the transcriptional corepressor CtBP and relieves CtBP-mediated repression of the E-cadherin gene. Molecular and Cellular Biology 2004 24 23 10223 10235 2-s2.0-8644237368 10.1128/MCB.24.23.10223-10235.2004 (Pubitemid 39507861)
60. Lin X., Liang Y. Y., Sun B., Liang M., Shi Y., Brunicardi F. C., Shi Y., Feng X. H., Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription. Molecular and Cellular Biology 2003 23 24 9081 9093 2-s2.0-0344629431 10.1128/MCB.23.24.9081-9093.2003 (Pubitemid 37499798)
61. Sierra J., Yoshida T., Joazeiro C. A., Jones K. A., The APC tumor suppressor counteracts β -catenin activation and H3K4 methylation at Wnt target genes. Genes and Development 2006 20 5 586 600 2-s2.0-33644763022 10.1101/gad.1385806 (Pubitemid 43345324)
62. Nadauld L. D., Phelps R., Moore B. C., Eisinger A., Sandoval I. T., Chidester S., Peterson P. W., Manos E. J., Sklow B., Burt R. W., Jones D. A., Adenomatous polyposis coli control of C-terminal binding protein-1 stability regulates expression of intestinal retinol dehydrogenases. The Journal of Biological Chemistry 2006 281 49 37828 37835 2-s2.0-33845973009 10.1074/jbc.M602119200 (Pubitemid 46042085)
63. Phelps R. A., Chidester S., Dehghanizadeh S., Phelps J., Sandoval I. T., Rai K., Broadbent T., Sarkar S., Burt R. W., Jones D. A., A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 2009 137 4 623 634 2-s2.0-65549159598 10.1016/j.cell.2009.02.037
64. Paliwal S., Pande S., Kovi R. C., Sharpless N. E., Bardeesy N., Grossman S. R., Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis. Molecular and Cellular Biology 2006 26 6 2360 2372 2-s2.0-33644758569 10.1128/MCB.26.6.2360-2372.2006 (Pubitemid 43346935)
65. Zhang Q., Nottke A., Goodman R. H., Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2005 102 8 2802 2807 2-s2.0-14544297432 10.1073/pnas.0409373102 (Pubitemid 40299873)
66. Wang S. Y., Iordanov M., Zhang Q., c-Jun NH2-terminal kinase promotes apoptosis by down-regulating the transcriptional co-repressor CtBP. The Journal of Biological Chemistry 2006 281 46 34810 34815 2-s2.0-33845942768 10.1074/jbc.M607484200 (Pubitemid 46036520)
67. Perissi V., Scafoglio C., Zhang J., Ohgi K. A., Rose D. W., Glass C. K., Rosenfeld M. G., TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. Molecular Cell 2008 29 6 755 766 2-s2.0-40849086600 10.1016/j.molcel.2008.01.020 (Pubitemid 351400927)
68. Wang Y., Liu F., Mao F., Interaction with CCNH/CDK7 stabilizes CtBP2 and promotes cancer cell migration. The Journal of Biological Chemistry 2013 288 13 9028 9034
69. Kegel K. B., Meloni A. R., Yi Y., Kim Y. J., Doyle E., Cuiffo B. G., Sapp E., Wang Y., Qin Z. H., Don Chen J., Nevins J. R., Aronin N., Difiglia M., Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. The Journal of Biological Chemistry 2002 277 9 7466 7476 2-s2.0-18544368523 10.1074/jbc.M103946200 (Pubitemid 34953144)
70. Kim S. C., Kim Y. S., Jetten A. M., Krüppel-like zinc finger protein Gli-similar 2 (Glis2) represses transcription through interaction with C-terminal binding protein 1 (CtBP1). Nucleic Acids Research 2005 33 21 6805 6815 2-s2.0-29244452102 10.1093/nar/gki985 (Pubitemid 41830486)
71. Haga Y., Miwa N., Jahangeer S., Okada T., Nakamura S. I., CtBP1/BARS is an activator of phospholipase D1 necessary for agonist-induced macropinocytosis. EMBO Journal 2009 28 9 1197 1207 2-s2.0-65649126338 10.1038/emboj.2009.78
72. Madison D. L., Lundblad J. R., C-terminal binding protein and poly(ADP)ribose polymerase 1 contribute to repression of the p21waf1/cip1 promoter. Oncogene 2010 29 45 6027 6039 2-s2.0-78149470107 10.1038/onc.2010.338
73. Murakami A., Ishida S., Thurlow J., Revest J. M., Dickson C., SOX6 binds CtBP2 to repress transcription from the Fgf-3 promoter. Nucleic Acids Research 2001 29 16 3347 3355 2-s2.0-0035881013 (Pubitemid 32799107)
74. Oswald F., Winkler M., Cao Y., Astrahantseff K., Bourteele S., Knöchel W., Borggrefe T., RBP-J /SHARP recruits CtIP/CtBP corepressors to silence notch target genes. Molecular and Cellular Biology 2005 25 23 10379 10390 2-s2.0-27944491856 10.1128/MCB.25.23.10379-10390.2005 (Pubitemid 41681962)
75. Perdomo J., Crossley M., The Ikaros family protein Eos associates with C-terminal-binding protein corepressors. European Journal of Biochemistry 2002 269 23 5885 5892 2-s2.0-0036445686 10.1046/j.1432-1033.2002.03313.x (Pubitemid 35425586)
76. Perry C., Pick M., Podoly E., Gilboa-Geffen A., Zimmerman G., Sklan E. H., Ben-Shaul Y., Diamant S., Soreq H., Acetylcholinesterase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia. Leukemia 2007 21 7 1472 1480 2-s2.0-34250726519 10.1038/sj.leu.2404722 (Pubitemid 46965289)
77. Purbey P. K., Singh S., Notani D., Kumar P. P., Limaye A. S., Galande S., Acetylation-dependent interaction of SATB1 and CtBP1 mediates transcriptional repression by SATB1. Molecular and Cellular Biology 2009 29 5 1321 1337 2-s2.0-61749083541 10.1128/MCB.00822-08
78. Riefler G. M., Firestein B. L., Binding of neuronal nitric-oxide synthase (nNOS) to carboxyl-terminal-binding protein (CtBP) changes the localization of ctbp from the nucleus to the cytosol: a novel function for targeting by the PDZ domain of nNOS. The Journal of Biological Chemistry 2001 276 51 48262 48268 2-s2.0-0035930601
79. Roukens M. G., Alloul-Ramdhani M., Baan B., Kobayashi K., Peterson-Maduro J., Van Dam H., Schulte-Merker S., Baker D. A., Control of endothelial sprouting by a Tel-CtBP complex. Nature Cell Biology 2010 12 10 933 942 2-s2.0-77957595050 10.1038/ncb2096
80. Saijo K., Collier J. G., Li A. C., Katzenellenbogen J. A., Glass C. K., An ADIOL-ER β -CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 2011 145 4 584 595 2-s2.0-79955788943 10.1016/j.cell.2011.03.050
81. Schuierer M., Hilger-Eversheim K., Dobner T., Bosserhoff A. K., Moser M., Turner J., Crossley M., Buettner R., Induction of AP-2 α expression by adenoviral infection involves inactivation of the AP-2rep transcriptional corepressor CtBP1. The Journal of Biological Chemistry 2001 276 30 27944 27949 2-s2.0-0035958871 10.1074/jbc.M100070200
82. Xia Z. B., Anderson M., Diaz M. O., Zeleznik-Le N. J., MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8342 8347 2-s2.0-0038492426 10.1073/pnas.1436338100 (Pubitemid 36842547)
83. Yang J., Everett A. D., Hepatoma-derived growth factor represses SET and MYND domain containing 1 gene expression through interaction with C-terminal binding protein. Journal of Molecular Biology 2009 386 4 938 950 2-s2.0-60149109389 10.1016/j.jmb.2008.12.080
84. Zaidi N. F., Kuplast K. G., Washicosky K. J., Kajiwara Y., Buxbaum J. D., Wasco W., Calsenilin interacts with transcriptional co-repressor C-terminal binding protein(s). Journal of Neurochemistry 2006 98 4 1290 1301 2-s2.0-33746398088 10.1111/j.1471-4159.2006.03972.x (Pubitemid 44127802)
85. Hamada F., Bienz M., The APC tumor suppressor binds to C-terminal binding protein to divert nuclear β -catenin from TCF. Developmental Cell 2004 7 5 677 685 2-s2.0-7744246985 10.1016/j.devcel.2004.08.022 (Pubitemid 39462688)
86. Zhang Q., Yoshimatsu Y., Hildebrand J., Frisch S. M., Goodman R. H., Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 2003 115 2 177 186 2-s2.0-0142258245 10.1016/S0092-8674(03)00802-X (Pubitemid 37329581)
87. Zou F., Xu J., Fu H., Different functions of HIPK2 and CtBP2 in traumatic brain injury. Journal of Molecular Neuroscience 2013 49 2 395 408
88. Perissi V., Scafoglio C., Zhang J., Ohgi K. A., Rose D. W., Glass C. K., Rosenfeld M. G., TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. Molecular Cell 2008 29 6 755 766 2-s2.0-40849086600 10.1016/j.molcel.2008.01.020 (Pubitemid 351400927)
89. Kovi R. C., Paliwal S., Pande S., Grossman S. R., An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis. Cell Death and Differentiation 2010 17 3 513 521 2-s2.0-76749166966 10.1038/cdd.2009.140
90. Chen Y. W., Paliwal S., Draheim K., Grossman S. R., Lewis B. C., P19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to c-terminal binding protein. Cancer Research 2008 68 2 476 482 2-s2.0-39049124311 10.1158/0008-5472.CAN-07-1960 (Pubitemid 351380074)
91. Choi H. J., Lee J. M., Kim H., Nam H. J., Shin H. J. R., Kim D., Ko E., Noh D. Y., Kim K. I., Kim J. H., Baek S. H., Bcl3-dependent stabilization of CtBP1 is crucial for the inhibition of apoptosis and tumor progression in breast cancer. Biochemical and Biophysical Research Communications 2010 400 3 396 402 2-s2.0-77956917232 10.1016/j.bbrc.2010.08.084
92. Dammer E. B., Sewer M. B., Phosphorylation of CtBP1 by cAMP-dependent protein kinase modulates induction of CYP17 by stimulating partnering of CtBP1 and 2. The Journal of Biological Chemistry 2008 283 11 6925 6934 2-s2.0-43749119417 10.1074/jbc.M708432200
93. Kim J. H., Choi S. Y., Kang B. H., AMP-activated protein kinase phosphorylates CtBP1 and down-regulates its activity. Biochemical and Biophysical Research Communications 2013 431 1 8 13
94. Lee J. S., Lee S. K., Youn H. D., Yoo S. J., C-terminal binding protein-mediated transcriptional repression is regulated by X-linked inhibitor of apoptosis protein. Biochemical and Biophysical Research Communications 2012 417 1 175 181
95. Lee J. S., Yoo S. J., C-terminus of Hsc70-interacting protein regulates C-terminal binding protein 2 and the expression of its target genes. Biochemical and Biophysical Research Communications 2013 432 3 418 424
96. Merrill J. C., Kagey M. H., Melhuish T. A., Powers S. E., Zerlanko B. J., Wotton D., Inhibition of CtBP1 activity by Akt-mediated phosphorylation. Journal of Molecular Biology 2010 398 5 657 671 2-s2.0-77952317325 10.1016/j.jmb.2010.03.048
97. Barnes C. J., Vadlamudi R. K., Mishra S. K., Jacobson R. H., Li F., Kumar R., Functional inactivation of a transcriptional corepressor by a signaling kinase. Nature Structural Biology 2003 10 8 622 628 2-s2.0-0043125507 10.1038/nsb957 (Pubitemid 36944715)
98. Lin X., Sun B., Liang M., Liang Y. Y., Gast A., Hildebrand J., Brunicardi F. C., Melchior F., Feng X. H., Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Molecular Cell 2003 11 5 1389 1396 2-s2.0-0038054467 10.1016/S1097-2765(03)00175-8 (Pubitemid 36645156)
99. Merrill J. C., Melhuish T. A., Kagey M. H., Yang S. H., Sharrocks A. D., Wotton D., A role for non-covalent SUMO interaction motifs in Pc2/CBX4 E3 activity. PLoS ONE 2010 5 1 2-s2.0-77649328923 10.1371/journal.pone.0008794 e8794
100. Kagey M. H., Melhuish T. A., Powers S. E., Wotton D., Multiple activities contribute to Pc2 E3 function. EMBO Journal 2005 24 1 108 119 2-s2.0-13244271351 10.1038/sj.emboj.7600506 (Pubitemid 40188468)
101. Kagey M. H., Melhuish T. A., Wotton D., The polycomb protein Pc2 is a SUMO E3. Cell 2003 113 1 127 137 2-s2.0-0037418829 10.1016/S0092-8674(03)00159-4 (Pubitemid 36411965)
102. Zhao L. J., Subramanian T., Zhou Y., Chinnadurai G., Acetylation by p300 regulates nuclear localization and function of the transcriptional corepressor CtBP2. The Journal of Biological Chemistry 2006 281 7 4183 4189 2-s2.0-33645224806 10.1074/jbc.M509051200 (Pubitemid 43847846)
103. Warburg O., On the origin of cancer cells. Science 1956 123 3191 309 314 2-s2.0-12444279265
104. Warburg O., On respiratory impairment in cancer cells. Science 1956 124 3215 269 270 2-s2.0-0001221508
105. Warburg O., Wind F., Negelein E., The metabolism of tumors in the body. The Journal of General Physiology 1927 8 6 519 530
106. Dang C. V., Hamaker M., Sun P., Le A., Gao P., Therapeutic targeting of cancer cell metabolism. Journal of Molecular Medicine 2011 89 3 205 212 2-s2.0-79955759406 10.1007/s00109-011-0730-x
107. Kim J. W., Dang C. V., Cancer's molecular sweet tooth and the warburg effect. Cancer Research 2006 66 18 8927 8930 2-s2.0-33749478922 10.1158/0008-5472.CAN-06-1501 (Pubitemid 44521105)
108. Koppenol W. H., Bounds P. L., Dang C. V., Otto Warburg's contributions to current concepts of cancer metabolism. Nature Reviews Cancer 2011 11 5 325 337 2-s2.0-79955398591 10.1038/nrc3038
109. Bui T., Thompson C. B., Cancer's sweet tooth. Cancer Cell 2006 9 6 419 420 2-s2.0-33744826296 10.1016/j.ccr.2006.05.012 (Pubitemid 43832194)
110. DeBerardinis R. J., Lum J. J., Hatzivassiliou G., Thompson C. B., The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metabolism 2008 7 1 11 20 2-s2.0-37449024702 10.1016/j.cmet.2007.10.002
111. Vander Heiden M. G., Cantley L. C., Thompson C. B., Understanding the warburg effect: the metabolic requirements of cell proliferation. Science 2009 324 5930 1029 1033 2-s2.0-66249108601 10.1126/science.1160809
112. Silva J. P., Wahlestedt C., Role of Sirtuin 1 in metabolic regulation. Drug Discovery Today 2010 15 17-18 781 791 2-s2.0-77956462423 10.1016/j.drudis.2010.07.001
113. Kyrylenko S., Baniahmad A., Sirtuin family: a link to metabolic signaling and senescence. Current Medicinal Chemistry 2010 17 26 2921 2932 2-s2.0-77955608578 10.2174/092986710792065009
114. Bürkle A., DNA repair and PARP in aging. Free Radical Research 2006 40 12 1295 1302 2-s2.0-33750735356 10.1080/10715760600915288 (Pubitemid 44698279)
115. Aly A., Ganesan S., BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability. Journal of Molecular Cell Biology 2011 3 1 66 74 2-s2.0-79951501575 10.1093/jmcb/mjq055
116. Krishnakumar R., Kraus W. L., The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Molecular Cell 2010 39 1 8 24 2-s2.0-77954274504 10.1016/j.molcel.2010.06.017
117. Chinnadurai G., CtBP, an unconventional transcriptional torepressor in development and oncogenesis. Molecular Cell 2002 9 2 213 224 2-s2.0-0036190459 10.1016/S1097-2765(02)00443-4 (Pubitemid 34195548)
118. Chinnadurai G., CtBP family proteins: more than transcriptional corepressors. BioEssays 2003 25 1 9 12 2-s2.0-0037232925 10.1002/bies.10212 (Pubitemid 36093319)
119. Chinnadurai G., Transcriptional regulation by C-terminal binding proteins. International Journal of Biochemistry and Cell Biology 2007 39 9 1593 1607 2-s2.0-34447632818 10.1016/j.biocel.2007.01.025 (Pubitemid 47088308)
120. Chinnadurai G., The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Research 2009 69 3 731 734 2-s2.0-59149096408 10.1158/0008-5472.CAN-08-3349
121. Verdin E., Hirschey M. D., Finley L. W. S., Haigis M. C., Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends in Biochemical Sciences 2010 35 12 669 675 2-s2.0-78649328799 10.1016/j.tibs.2010.07.003
122. Zhang Q., Piston D. W., Goodman R. H., Regulation of corepressor function by nuclear NADH. Science 2002 295 5561 1895 1897 2-s2.0-0037040581 10.1126/science.1069300 (Pubitemid 34214127)
123. Boyd J. M., Subramanian T., Schaeper U., La Regina M., Bayley S., Chinnadurai G., A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation tumorigenesis and metastasis. EMBO Journal 1993 12 2 469 478 2-s2.0-0027509346 (Pubitemid 23073693)
124. Sollerbrant K., Chinnadurai G., Svensson C., The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation. Nucleic Acids Research 1996 24 13 2578 2584 2-s2.0-0029901451 10.1093/nar/24.13.2578 (Pubitemid 26237158)
125. Molloy D. P., Milner A. E., Yakub I. K., Chinnadurai G., Gallimore P. H., Grand R. J. A., Structural determinants present in the C-terminal binding protein binding site of adenovirus early region 1A proteins. The Journal of Biological Chemistry 1998 273 33 20867 20876 2-s2.0-0032516847 10.1074/jbc.273.33.20867 (Pubitemid 28385366)
126. Postigo A. A., Dean D. C., ZEB represses transcription through interaction with the corepressor CtBP. Proceedings of the National Academy of Sciences of the United States of America 1999 96 12 6683 6688 2-s2.0-0033536047 10.1073/pnas.96.12.6683 (Pubitemid 29274943)
127. Schaeper U., Subramanian T., Lim L., Boyd J. M., Chinnadurai G., Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif. The Journal of Biological Chemistry 1998 273 15 8549 8552 2-s2.0-0032502782 10.1074/jbc.273.15.8549 (Pubitemid 28176126)
128. Minamisawa N., ANGUSTIFOLIA, a plant homolog of CtBP/BARS, functions outside the nucleus. The Plant Journal 2011 68 5 788 799
129. Chen S., Whetstine J. R., Ghosh S., Hanover J. A., Gali R. R., Grosu P., Shi Y., The conserved NAD(H)-dependent corepressor CTBP-1 regulates Caenorhabditis elegans life span. Proceedings of the National Academy of Sciences of the United States of America 2009 106 5 1496 1501 2-s2.0-60849116960 10.1073/pnas.0802674106
130. Grooteclaes M. L., Frisch S. M., Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 2000 19 33 3823 3828 2-s2.0-0034601442 (Pubitemid 30621190)
131. Kalluri R., Weinberg R. A., The basics of epithelial-mesenchymal transition. The Journal of Clinical Investigation 2009 119 6 1420 1428 2-s2.0-67650999875 10.1172/JCI39104
132. Glasspool R. M., Burns S., Hoare S. F., Svensson C., Keith W. N., The hTERT and hTERC telomerase gene promoters are activated by the second exon of the adenoviral protein, E1A, identifying the transcriptional corepressor CtBP as a potential repressor of both genes. Neoplasia 2005 7 6 614 622 2-s2.0-22044447523 10.1593/neo.04766 (Pubitemid 40967762)
133. Garriga-Canut M., Schoenike B., Qazi R., Bergendahl K., Daley T. J., Pfender R. M., Morrison J. F., Ockuly J., Stafstrom C., Sutula T., Roopra A., 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nature Neuroscience 2006 9 11 1382 1387 2-s2.0-33750443292 10.1038/nn1791 (Pubitemid 44646210)
134. Drabsch Y., Ten Dijke P., TGF-beta signalling and its role in cancer progression and metastasis. Cancer and Metastasis Reviews 2012 3-4 553 568
135. Palmer S., Brouillet J. P., Kilbey A., Fulton R., Walker M., Crossley M., Bartholomew C., Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. The Journal of Biological Chemistry 2001 276 28 25834 25840 2-s2.0-0035854745 10.1074/jbc.M102343200 (Pubitemid 37412785)
136. Izutsu K., Kurokawa M., Imai Y., Ichikawa M., Asai T., Maki K., Mitani K., Hirai H., The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP. Oncogene 2002 21 17 2695 2703 2-s2.0-0037129369 10.1038/sj.onc.1205356 (Pubitemid 34478327)
137. Senyuk V., Chakraborty S., Mikhail F. M., Zhao R., Chi Y., Nucifora G., The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells. Oncogene 2002 21 20 3232 3240 2-s2.0-0037046507 10.1038/sj/onc/1205436 (Pubitemid 34548094)
138. Hildebrand J. D., Soriano P., Overlapping and unique roles for C-terminal binding protein 1 (CtBP1) and CtBP2 during mouse development. Molecular and Cellular Biology 2002 22 15 5296 5307 2-s2.0-0036314926 10.1128/MCB.22.15.5296- 5307.2002 (Pubitemid 34755743)
139. Kumar V., Carlson J. E., Ohgi K. A., Edwards T. A., Rose D. W., Escalante C. R., Rosenfeld M. G., Aggarwal A. K., Transcription corepressor CtBP is an NAD+-regulated dehydrogenase. Molecular Cell 2002 10 4 857 869 2-s2.0-0036810314 10.1016/S1097-2765(02)00650-0 (Pubitemid 35335640)
140. Balasubramanian P., Zhao L. J., Chinnadurai G., Nicotinamide adenine dinucleotide stimulates oligomerization, interaction with adenovirus E1A and an intrinsic dehydrogenase activity of CtBP. FEBS Letters 2003 537 1-3 157 160 2-s2.0-0037468522 10.1016/S0014-5793(03)00119-4 (Pubitemid 36246694)
141. Fjeld C. C., Birdsong W. T., Goodman R. H., Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proceedings of the National Academy of Sciences of the United States of America 2003 100 16 9202 9207 2-s2.0-0041923828 10.1073/pnas.1633591100 (Pubitemid 37033907)
142. Sutrias-Grau M., Arnosti D. N., CtBP contributes quantitatively to Knirps repression activity in an NAD binding-dependent manner. Molecular and Cellular Biology 2004 24 13 5953 5966 2-s2.0-2942750116 10.1128/MCB.24.13.5953-5966.2004 (Pubitemid 38787978)
143. Zhang Y. W., Arnosti D. N., Conserved catalytic and C-terminal regulatory domains of the C-terminal binding protein corepressor fine-tune the transcriptional response in development. Molecular and Cellular Biology 2011 31 2 375 384 2-s2.0-78751521453 10.1128/MCB.00772-10
144. Subramanian T., Chinnadurai G., Association of class I histone deacetylases with transcriptional corepressor CtBP. FEBS Letters 2003 540 1-3 255 258 2-s2.0-0037430968 10.1016/S0014-5793(03)00275-8 (Pubitemid 36398067)
145. Chang Y., Sun L., Kokura K., MPP8 mediates the interactions between DNA methyltransferase Dnmt3a and H3K9 methyltransferase GLP/G9a. Nature Communications 2011 2, article 533
146. Leung D. C., Dong K. B., Maksakova I. A., Goyal P., Appanah R., Lee S., Tachibana M., Shinkai Y., Lehnertz B., Mager D. L., Rossi F., Lorincz M. C., Lysine methyltransferase G9a is required for de novo DNA methylation and the establishment, but not the maintenance, of proviral silencing. Proceedings of the National Academy of Sciences of the United States of America 2011 108 14 5718 5723 2-s2.0-79955042533 10.1073/pnas.1014660108
147. Li B., Zhou J., Liu P., Hu J., Jin H., Shimono Y., Takahashi M., Xu G., Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a. Biochemical Journal 2007 405 2 369 378 2-s2.0-34447127473 10.1042/BJ20061873 (Pubitemid 47075172)
148. Oma Y., Nishimori K., Harata M., The brain-specific actin-related protein ArpN α interacts with the transcriptional co-repressor CtBP. Biochemical and Biophysical Research Communications 2003 301 2 521 528 2-s2.0-0037423699 10.1016/S0006-291X(02)03073-5 (Pubitemid 36279271)
149. Deltour S., Pinte S., Guerardel C., Wasylyk B., Leprince D., The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Molecular and Cellular Biology 2002 22 13 4890 4901 2-s2.0-0036274143 10.1128/MCB.22.13.4890-4901.2002 (Pubitemid 34620422)
150. Lopez-Garcia J., Periyasamy M., Thomas R. S., Christian M., Leao M., Jat P., Kindle K. B., Heery D. M., Parker M. G., Buluwela L., Kamalati T., Ali S., ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases. Nucleic Acids Research 2006 34 21 6126 6136 2-s2.0-33845639258 10.1093/nar/gkl875 (Pubitemid 44942734)
151. Cuilliere-Dartigues P., El-Bchiri J., Krimi A., Buhard O., Fontanges P., Fléjou J. F., Hamelin R., Duval A., TCF-4 isoforms absent in TCF-4 mutated MSI-H colorectal cancer cells colocalize with nuclear CtBP and repress TCF-4-mediated transcription. Oncogene 2006 25 32 4441 4448 2-s2.0-33646553656 10.1038/sj.onc.1209471 (Pubitemid 44141632)
152. Alpatov R., Shi Y., Munguba G. C., Moghimi B., Joo J. H., Bungert J., Sugrue S. P., Corepressor CtBP and nuclear speckle protein Pnn/DRS differentially modulate transcription and splicing of the E-cadherin gene. Molecular and Cellular Biology 2008 28 5 1584 1595 2-s2.0-40749155486 10.1128/MCB.00421-07
153. Zhao L. J., Subramanian T., Zhou Y., Chinnadurai G., Acetylation by p300 regulates nuclear localization and function of the transcriptional corepressor CtBP2. The Journal of Biological Chemistry 2006 281 7 4183 4189 2-s2.0-33645224806 10.1074/jbc.M509051200 (Pubitemid 43847846)
154. Kagey M. H., Melhuish T. A., Powers S. E., Wotton D., Multiple activities contribute to Pc2 E3 function. EMBO Journal 2005 24 1 108 119 2-s2.0-13244271351 10.1038/sj.emboj.7600506 (Pubitemid 40188468)
155. Kagey M. H., Melhuish T. A., Wotton D., The polycomb protein Pc2 is a SUMO E3. Cell 2003 113 1 127 137 2-s2.0-0037418829 10.1016/S0092-8674(03)00159-4 (Pubitemid 36411965)
156. Merrill J. C., Kagey M. H., Melhuish T. A., Powers S. E., Zerlanko B. J., Wotton D., Inhibition of CtBP1 activity by Akt-mediated phosphorylation. Journal of Molecular Biology 2010 398 5 657 671 2-s2.0-77952317325 10.1016/j.jmb.2010.03.048
157. Paliwal S., Pande S., Kovi R. C., Sharpless N. E., Bardeesy N., Grossman S. R., Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis. Molecular and Cellular Biology 2006 26 6 2360 2372 2-s2.0-33644758569 10.1128/MCB.26.6.2360-2372.2006 (Pubitemid 43346935)
158. Valente C., Turacchio G., Mariggio S., A 14-3-3gamma dimer-based scaffold bridges CtBP1-S/BARS to PI(4)KIIIbeta to regulate post-Golgi carrier formation. Nature Cell Biology 2012 14 4 343 354
159. Bonazzi M., Spanò S., Turacchio G., Cericola C., Valente C., Colanzi A., Kweon H. S., Hsu V. W., Polishchuck E. V., Polishchuck R. S., Sallese M., Pulvirenti T., Corda D., Luini A., CtBP3/BARS drives membrane fission in dynamin-independent transport pathways. Nature Cell Biology 2005 7 6 570 580 2-s2.0-20444414481 10.1038/ncb1260 (Pubitemid 40796980)
160. Hidalgo Carcedo C., Donazzi M., Spano S., Turacchio G., Colanzi A., Luini A., Corda D., Mitotic Golgi partitioning is driven by the membrane-fissioning protein CtBP3/BARS. Science 2004 305 5680 93 96 2-s2.0-3042795657 10.1126/science.1097775 (Pubitemid 38869379)
161. Welgert R., Silletta M. G., Spanò S., Turacchie G., Cericola C., Colanzi A., Senatore S., Mancini R., Pollshchuk E. V., Salmona M., Facchiano F., Burger K. N. J., Mironov A., Luini A., Corda D., CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid. Nature 1999 402 6760 429 433 2-s2.0-0033604565 10.1038/46587 (Pubitemid 129544833)
162. Gallop J. L., Butler P. J. G., McMahon H. T., Endophilin and CtBP/BARS are not acyl transferases in endocytosis or Golgi fission. Nature 2005 438 7068 675 678 2-s2.0-28444437745 10.1038/nature04136 (Pubitemid 41740578)
163. Corda D., Colanzi A., Luini A., The multiple activities of CtBP/BARS proteins: the Golgi view. Trends in Cell Biology 2006 16 3 167 173 2-s2.0-33644821441 10.1016/j.tcb.2006.01.007 (Pubitemid 43358005)
164. Monleón I., Iturralde M., Martínez-Lorenzo M. J., Monteagudo L., Lasierra P., Larrad L., Piñeiro A., Naval J., Alava M. A., Anel A., Lack of Fas/CD95 surface expression in highly proliferative leukemic cell lines correlates with loss of CtBP/BARS and redirection of the protein toward giant lysosomal structures. Cell Growth and Differentiation 2002 13 7 315 324 2-s2.0-18444401750 (Pubitemid 34791205)
165. St Johnston D., Sanson B., Epithelial polarity and morphogenesis. Current Opinion in Cell Biology 2011 23 5 540 546
166. Martin-Belmonte F., Perez-Moreno M., Epithelial cell polarity, stem cells and cancer. Nature Reviews Cancer 2012 12 1 23 38
167. McCaffrey L. M., Macara I. G., Epithelial organization, cell polarity and tumorigenesis. Trends in Cell Biology 2011 21 12 727 735
168. Spyer M., Allday M. J., The transcriptional co-repressor C-terminal Binding Protein (CtBP) associates with centrosomes during mitosis. Cell Cycle 2006 5 5 530 537 2-s2.0-33644764066 (Pubitemid 43340532)
169. Kelsom C., Lu W., Uncovering the link between malfunctions in Drosophila neuroblast asymmetric cell division and tumorigenesis. Cell & Bioscience 2012 2, article 38
170. Snow J. W., Kim J., Currie C. R., Xu J., Orkin S. H., Sumoylation regulates interaction of FOG1 with C-terminal-binding protein (CTBP). The Journal of Biological Chemistry 2010 285 36 28064 28075 2-s2.0-77956251063 10.1074/jbc.M109.096909
171. Morishita K., Role of CtBP-binding transcription factors in leukemogenesis. Rinsho Ketsueki 2009 50 3 160 167 2-s2.0-70449713632
172. Straza M. W., Paliwal S., Kovi R. C., Rajeshkumar B., Trenh P., Parker D., Whalen G. F., Lyle S., Schiffer C. A., Grossman S. R., Therapeutic targeting of C-terminal binding protein in human cancer. Cell Cycle 2010 9 18 3740 3750 2-s2.0-77957003489 10.4161/cc.9.18.12936
173. Schneikert J., Brauburger K., Behrens J., APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC. Human Molecular Genetics 2011 20 18 3554 3564
174. Peña C., García J. M., García V., Silva J., Domínguez G., Rodríguez R., Maximiano C., García De Herreros A., Muñoz A., Bonilla F., The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas. International Journal of Cancer 2006 119 9 2098 2104 2-s2.0-33748868126 10.1002/ijc.22083 (Pubitemid 44423667)
175. Zhang Q., Wang S. Y., Nottke A. C., Rocheleau J. V., Piston D. W., Goodman R. H., Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proceedings of the National Academy of Sciences of the United States of America 2006 103 24 9029 9033 2-s2.0-33745172454 10.1073/pnas.0603269103 (Pubitemid 43902527)
176. Deng H., Liu J., Deng Y., CtBP1 is expressed in Melanoma and represses the transcription of p16INK4a and Brca1. Journal of Investigative Dermatology 2013 133 5 1294 1301
177. Deng Y., Liu J., Han G., Lu S. L., Wang S. Y., Malkoski S., Tan A. C., Deng C., Wang X. J., Zhang Q., Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1. Oncogene 2010 29 50 6603 6608 2-s2.0-78650308691 10.1038/onc.2010.406
178. Guan C., Shi H., Wang H., CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16(INK4A.). Journal of Cellular Biochemistry 2013 114 6 1343 1354
179. Barroilhet L., Yang J., Hasselblatt K., C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors. Oncogene 2012 10.1038/onc.2012.380
180. Wang R., Asangani I. A., Chakravarthi B. V., Role of transcriptional corepressor CtBP1 in prostate cancer progression. Neoplasia 2012 14 10 905 914
181. Birts C. N., Harding R., Soosaipillai G., Halder T., Azim-Araghi A., Darley M., Cutress R. I., Bateman A. C., Blaydes J. P., Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance. Biology of the Cell 2011 103 1 1 19 2-s2.0-78650770421 10.1042/BC20100067
182. Di L.-J., Fernandez A. G., De Siervi A., Longo D. L., Gardner K., Transcriptional regulation of BRCA1 expression by a metabolic switch. Nature Structural & Molecular Biology 2010 17 12 1406 1413
183. Zhao L. Z., Chinnadurai G., Incapacitating CtBP to kill cancer. Cell Cycle 2010 9 18 3645 3646 2-s2.0-77957006777 10.4161/cc.9.18.13221
184. Deng Y., Deng H., Liu J., Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer. Molecular Carcinogenesis 2012 51 6 500 507
185. Di L. J., Byun J. S., Wong M. M., Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer. Nature Communications 2013 4, article 1449
186. Hanahan D., Weinberg R. A., The hallmarks of cancer. Cell 2000 100 1 57 70 2-s2.0-0034614637 (Pubitemid 30046295)
187. Valastyan S., Weinberg R. A., Tumor metastasis: molecular insights and evolving paradigms. Cell 2011 147 2 275 292
188. Hu Z., Fan C., Oh D. S., The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006 7, article 96
189. Perou C. M., Sørile T., Eisen M. B., Van De Rijn M., Jeffrey S. S., Ress C. A., Pollack J. R., Ross D. T., Johnsen H., Akslen L. A., Fluge Ø., Pergammenschlkov A., Williams C., Zhu S. X., Lønning P. E., Børresen-Dale A. L., Brown P. O., Botstein D., Molecular portraits of human breast tumours. Nature 2000 406 6797 747 752 2-s2.0-0034680102 10.1038/35021093
190. Network T. C. G. A., Comprehensive molecular portraits of human breast tumours. Nature 2012 490 7418 61 70
191. Prat A., Parker J. S., Karginova O., Fan C., Livasy C., Herschkowitz J. I., He X., Perou C. M., Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Research 2010 12 5, article R68 2-s2.0-78049308800 10.1186/bcr2635
192. Millikan R. C., Newman B., Tse C. K., Moorman P. G., Conway K., Smith L. V., Labbok M. H., Geradts J., Bensen J. T., Jackson S., Nyante S., Livasy C., Carey L., Earp H. S., Perou C. M., Epidemiology of basal-like breast cancer. Breast Cancer Research and Treatment 2008 109 1 123 139 2-s2.0-42149134292 10.1007/s10549-007-9632-6 (Pubitemid 351538762)
193. Herschkowitz J. I., Zhao W., Zhang M., Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proceedings of the National Academy of Sciences of the United States of America 2012 109 8 2778 2783
194. Livasy C. A., Karaca G., Nanda R., Tretiakova M. S., Olopade O. I., Moore D. T., Perou C. M., Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Modern Pathology 2006 19 2 264 271 2-s2.0-30944450821 10.1038/modpathol.3800528 (Pubitemid 43117611)
195. Koh M., Lee J. C., Min C., Moon A., A novel metformin derivative, HL010183, inhibits proliferation and invasion of triple-negative breast cancer cells. Bioorganic & Medicinal Chemistry 2013 21 8 2305 2313
196. Gandini S., Guerrieri-Gonzaga A., Puntoni M., DeCensi A., Metformin and breast cancer risk. Journal of Clinical Oncology 2013 31 7 973 974